Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (241-250 of 333) with videos related to

Pageof 34
Sort By:
Cancer Research|February 1, 1987
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumorsR Derynck, D V Goeddel, A Ullrich, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.
Blood|August 1, 1986
Treatment of hairy cell leukemia with recombinant alpha-interferonJ R Quesada, E M Hersh, J Manning, et al.
Journal of the National Cancer Institute|August 1, 1974
Immunodiagnosis of acute leukemia: detection of residual diseaseJ U Gutterman, G Mavligit, M A Burgess, et al.
Leukemia|February 1, 1993
Suppression of chronic myelogenous leukemia colony growth by interleukin-4Z Estrov, A B Markowitz, R Kurzrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Phase I study of multiple dose intramuscularly administered recombinant gamma interferonR Kurzrock, J R Quesada, M Talpaz, et al.
Cancer Treatment Reports|May 1, 1981
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effectsS P Richman, E M Hersh, J U Gutterman, et al.
Cancer|November 1, 1979
The use of leukocyte cell line culture supernatant for skin reaction testing in malignant melanomaA Rios, E M Hersh, J U Gutterman, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSFE H Estey, H M Kantarjian, M Beran, et al.
Pageof 34

Showing results (241-250 of 333) with videos related to

Sort By:
Pageof 34
Cancer Research|February 1, 1987
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumorsR Derynck, D V Goeddel, A Ullrich, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.
Blood|August 1, 1986
Treatment of hairy cell leukemia with recombinant alpha-interferonJ R Quesada, E M Hersh, J Manning, et al.
Journal of the National Cancer Institute|August 1, 1974
Immunodiagnosis of acute leukemia: detection of residual diseaseJ U Gutterman, G Mavligit, M A Burgess, et al.
Leukemia|February 1, 1993
Suppression of chronic myelogenous leukemia colony growth by interleukin-4Z Estrov, A B Markowitz, R Kurzrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Phase I study of multiple dose intramuscularly administered recombinant gamma interferonR Kurzrock, J R Quesada, M Talpaz, et al.
Cancer Treatment Reports|May 1, 1981
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effectsS P Richman, E M Hersh, J U Gutterman, et al.
Cancer|November 1, 1979
The use of leukocyte cell line culture supernatant for skin reaction testing in malignant melanomaA Rios, E M Hersh, J U Gutterman, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSFE H Estey, H M Kantarjian, M Beran, et al.
Pageof 34